Cinemark Holdings, Inc. (NYSE:CNK) Q3 2024 Earnings Call Transcript
Operator: Greetings and welcome to Cinemark Holdings Inc.’s Third Quarter 2024 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded.
Cinemark Holdings Inc. (CNK)
Market is closed
News
- 1 - 10
- Next >>
Should You be Optimistic on Cinemark Holdings (CNK)?
Third Point Management, a New York-based investment advisor, released its third-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Cinemark Holdings (CNK) Surged on Strong Results
Chartwell Investment Partners, LLC, an affiliate of Carillon Tower Advisers, Inc., released the “Carillon Chartwell Small Cap Value Fund” second quarter 2024 investor letter.
Cinemark Holdings, Inc. (NYSE:CNK) Q2 2024 Earnings Call Transcript
Operator: Welcome to the Cinemark Holdings Inc. Second Quarter 2024 Earnings Call. At this time, all participants are in a listen-only mode.
Cinemark Holdings, Inc. (NYSE:CNK) Q1 2024 Earnings Call Transcript
Cinemark Holdings, Inc. beats earnings expectations. Reported EPS is $0.19, expectations were $-0.21. Cinemark Holdings, Inc.
Cinemark Holdings, Inc. (NYSE:CNK) Q4 2023 Earnings Call Transcript
Operator: Hello, and welcome to the Cinemark Holdings Fourth Quarter 2023 Earnings Call and Webcast. [Operator Instructions] A question-and-answer session will follow the formal presentation.
Cinemark Holdings, Inc. (NYSE:CNK) Q3 2023 Earnings Call Transcript
Operator: Greetings, and welcome to the Cinemark Holdings Third Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.
Movie Studio and News Media Stocks List
In this article, we’ll discuss the 29 movie studio and news media stocks .
Cinemark Holdings, Inc. (NYSE:CNK) Q2 2023 Earnings Call Transcript
Operator: Greetings. Welcome to the Cinemark Holdings Second Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.
5 Best Short Squeeze Stocks to Buy Now
There was a surge in hedge fund ownership of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) during the third quarter of 2022, as the number of smart money shareholders of the company nearly doubled.
- 1 - 10
- Next >>
Billionaire Hedge Funds
